Background: Previous methods to measure glycohemoglobin (GHb) have been time-consuming or imprecise; we therefore developed a new enzymatic assay for GHb. Methods: Blood cells were first hemolyzed, and hemoglobin was digested with protease to yield fructosyl amino acid. Fructosyl amino acid oxidase acts on the fructosyl amino acid and generates hydrogen peroxide, which reacts with chromogens in the presence of peroxidase. Total hemoglobin was measured spectrometrically in the same reaction tube. The results were reported as the ratio of the concentrations of GHb and hemoglobin.
The HPLC method can detect abnormal Hb with favorable reproducibility and a CV Ͻ1% (7) (8) (9) (10) . However, a large dedicated device and a long run time are required. The HPLC method requires ϳ4 h to analyze 100 samples. In a laboratory measuring thousands of samples, dozens of HPLC devices are necessary. In addition, many personnel are needed to maintain the instrumentation.
The immunoassay can be adapted to an automated analyzer, and a large number of samples can be measured in a short time. However, with this method, the total Hb and the GHb need to be measured separately (11) (12) (13) . Moreover, the reproducibility is not good (CV, 3-5%), and the calibration curve is unstable and cannot be held for 24 h. Therefore, researchers and clinicians await a method that could solve these problems.
We describe a new enzymatic assay for measuring GHb in which Hb in the sample is digested with a specific protease to generate fructosyl amino acid (Fig. 1) .
Fructosyl amino acid reacts in the presence of fructosyl amino acid oxidase (FAOD) to generate H 2 O 2 , the concentration of which is proportional to that of GHb in the blood. Peroxidase (POD) catalyzes the reaction of H 2 O 2 and chromogen to develop color, which is proportional to the concentration of GHb in the sample. The total Hb concentration is obtained by measuring the color produced by Hb digested with the specific protease. The final result is reported as the concentration ratio of GHb to Hb.
Materials and Methods materials
Specimens were collected in potassium EDTA sample tubes (VENOJECT II DK; 2 mL; Terumo Corp.) from patients of the Omiya Medical Center, Jichi Medical School. Specimens for measurement were blood cells that were obtained from the collected specimens by centrifugation (RL-101 centrifuge and rotor TS-7; Tomy Seiko) at 1500g for 15 min. The specimens were chosen at random, so that they could not be linked with a specific patient.
Five samples with similar GHb values were collected from patients and from healthy persons and were mixed together to prepare the pooled sample.
reagents for the enzymatic assay
Three measurement reagents were used. Reagent 1 was composed of 80 mmol/L N-cyclohexyl-2-aminoethanesulfonic acid (Dojindo), 30 mmol/L MOPS (Dojindo), and 9 g/L polyoxyethylene lauryl ether (Nihon Surfactant Kogyo K. K.). Reagent 2 was composed of 4000 kU/L metalloproteinase (ARKRAY, Inc.); 2 mmol/L 2-(iodophenyl)-3-(2,4-dinitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt (WST-3, Dojindo); 3 mmol/L MES (Dojindo); and 5 mmol/L CaCl 2 . The metalloproteinase is a specific protease that has an optimum pH at 7.0 -8. 
enzymatic assay
To hemolyze the sample, we mixed 0.3 mL of Reagent 1 and 0.01 mL of blood cells in a 1.5-mL microtube. The sample was measured with an automated analyzer (JCA-BM12; JEOL Ltd.; Fig. 2 ). The Hb was resolved by the specific protease, and fructosyl amino acid was separated from Hb in 3-5 min. The total Hb concentration was measured by absorbance at an optional wavelength from 500 to 670 nm for ϳ5 min. FAOD produced H 2 O 2 from fructosyl amino acid. H 2 O 2 then reacted with DA-64 via POD, and the DA-64 was converted to Bindschedler's green, which has an absorbance maximum at 727 nm. The GHb concentration was determined by measuring the absorbance of Bindschedler's green at optional wavelength from 660 to 760 nm for ϳ8 min.
Calibration was performed with use of a calibrator before the first run every day. The calibration formula was a polygonal line. The calibrator measured zero, low, and high values; the GHb value; and the Hb value, which were based on values of standard material established by the Japanese Diabetic Society (JDS).
hplc method
To hemolyze the sample, we mixed 1.2 mL of diluted solution and 0.003 mL of blood cells in a 1.5-mL microtube. The sample was analyzed on the ADAMS-A1c HA-8160 (ARKRAY) based on the HPLC method. Calibration was performed daily with two calibrators containing different exclusive densities based on standard material established by the JDS.
immunoassay
To hemolyze the sample, we mixed 0.5 mL of diluted solution and 0.005 mL of blood cells in a 1.5-mL microtube. The sample was analyzed with an immunoassay (Rapidia-auto HbA1c; Fujirebio Inc.) on the automated analyzer (JCA-BM12). Calibration was performed daily with a calibrator containing five exclusive densities based on standard material established by JDS.
statistical analysis
Statistical analysis was performed with Excel 97 (Microsoft Corp.) software. The specimen can be whole blood or blood cells. Erythrocytes are hemolyzed by Reagent 1. Hb is digested with a specific protease in Reagent 2, and fructosyl amino acid is generated. Total Hb is measured by absorbance at an optional wavelength from 500 to 670 nm in ϳ4 min. FAOD in Reagent 3 reacts on this fructosyl amino acid and generates H 2 O 2 , which reacts with DA-64 via POD; the DA-64 is then converted to Bindschedler's green. GHb is measured by absorbance at an optional wavelength from 660 to 760 nm in ϳ8 min. Blood cells are hemolyzed by Reagent 1. The Hb is resolved by the specific protease, and fructosyl amino acid is separated from Hb in 3-5 min. The total Hb concentration is measured by absorbance at optional wavelength from 500 to 670 nm in ϳ5 min. FAOD produces H 2 O 2 from the fructosyl amino acid. H 2 O 2 reacts with DA-64 via POD; the DA-64 is then converted to Bindschedler's green. The GHb concentration is measured from the Bindschedler's green at an optional wavelength from 660 to 760 nm in ϳ8 min.
Results

within-run and total imprecision
Within-run imprecision was calculated by measuring three samples 20 times. The imprecision (CV) was 0.35% at a mean GHb of 4.2%, 0.22% at a mean GHb of 6.4%, and 0.19% at a mean GHb of 9.1%.
The total CVs for three samples measured over 20 days were 1.5%, 1.3%, and 1.1% at mean concentrations of 4.9%, 6.9%, and 10.2%. 
correlation between enzymatic assay and other methods
Regression analysis comparing the enzymatic assay (y) and the HPLC (x) method yielded the following: r ϭ 0.979; slope, 0.994 [95% confidence interval (CI), 0.986 -1.001]; y-intercept, 0.04% (95% CI, Ϫ0.09% to 0.01%); n ϭ 2854. The mean difference between the measured values for these methods was Ϫ0.08% GHb, with a 95% CI of Ϫ0.67% to 0.50% GHb (Fig. 3) .
The correlation between the enzymatic assay (y) and the immunoassay (x) was r ϭ 0.982 [slope, 1.002 (95% CI, 0.995-1.009); y-intercept, 0% (95% CI, Ϫ0.05% to 0.05%); n ϭ 2854]. The mean change in value for these methods was 0.01% GHb, with a 95% CI of Ϫ0.54% to 0.56% GHb (Fig. 4) . Because favorable correlation results were obtained, the measurement results for the enzymatic GHb method appear to be comparable to those of the conventional methods.
reference interval
Reference values for nondiabetic persons are 4.3-5.8%, with a mean of 5.0%, as established by the JDS.
influence of Hb concentration
For this experiment, we used three samples in which GHb concentrations were 5.2%, 7.5%, and 9.8%, respectively, of the total Hb. We placed aliquots of blood cells from these samples (0.003, 0.005, 0.007, 0.01, 0.013, or 0.015 mL) in 1.5-mL microtubes, added 0.3 mL of Reagent 1, and hemolyzed the cells in a vortex-type mixer.
The influence of the Hb concentration on the measured GHb value was as follows (Fig. 5) . Generally, as the amount of blood cells increased, the GHb value decreased. When the Hb concentration changed from 100 to 400 g/L, the GHb value changed from ϩ0.4% to Ϫ0.4%. In other words, the measured value was not influenced when the Hb concentration in the sample increased 400%. Thus, whole blood with a Hb concentration of 50-200 g/L can be used as the specimen by changing the dilution rate.
influence of plasma
For this experiment, we used three samples with GHb concentrations of 4.7%, 7.0%, and 8.9%, respectively. We placed 0.01-mL portions of blood cells from these samples in 1.5-mL microtubes and added 0, 0.005, 0.01, 0.015, or 0.02 mL of plasma. We then added 0.3 mL of Reagent 1 to the microtubes and hemolyzed the cells in a vortex-type mixer.
The influence of plasma on the measured GHb value was as follows (Fig. 6) . Generally, when plasma was added, the GHb value decreased. When 0.02 mL of plasma was added, the GHb value changed a maximum of Ϫ0.6%. Because fructosamine in plasma was not measured, the measured value did not increase. When the specimen was whole blood, we increased the specimen volume by 0.02 mL. The sample included ϳ0.01 mL plasma, but the measured value was influenced Ͻ0.3%.
influence of interfering substances
For the interference experiments, we used three samples in which the GHb concentrations were 4.7%, 6.5%, and 9.0%, respectively. We placed 0.01 mL of blood cells from these samples in 1.5-mL microtubes and added a solution of interfering substances (0, 0.005, or 0.01 mL). We then added 0.3 mL of Reagent 1 to these samples and hemolyzed the mixtures in a vortex-type mixer.
The interfering substances and the maximum concentrations used were as follows: ascorbic acid (200 mg/L), uric acid (200 mg/L), glucose (10 g/L), albumin (100 g/L; A-8022; Sigma Chemical Co.), bilirubin (200 mg/L; International Reagents Corp.). The influence of the interfering substances on the GHb values was as follows. When ascorbic acid, glucose, or uric acid was added up to the maximum concentration, we found no influence on GHb. The GHb concentration in the three samples was 5.2%, 7.5%, and 9.8%, respectively. The blood cells were hemolyzed by the addition of 0.3 mL of Reagent 1. The volume of blood cells was 0.003, 0.005, 0.007, 0.01, 0.013, or 0.015 mL. As the volume of blood cells increased, the GHb measured value decreased. When the concentration of Hb changed from 100 to 400 g/L, the measured GHb value changed from ϩ0.4% to Ϫ0.4%. Fig. 6 . Influence of plasma on GHb measurement.
The GHb concentration in the three samples was 4.7%, 7.0%, and 8.9%, respectively, of the total Hb. Blood cells (0.01 mL) and various amounts of plasma (0, 0.005, 0.01, 0.015, or 0.02 mL) were hemolyzed by the addition of 0.3 mL of Reagent 1. When plasma was added, the GHb value decreased. When 0.02 mL of plasma was added, the influence on the GHb measured value was Ϫ0.6% at the maximum. One milliliter of whole blood contains ϳ0.5 mL of plasma, but the measured value is influenced by Ͻ0.3%.
When 200 mg/L of bilirubin was added, the measured GHb value changed by Ϫ0.8%.
influence of sample preparation
Measured values were compared when the specimens were hemolyzed with Reagent 1 and analysis began 10 s, 5 min, and 30 min later, and when samples of blood cells were hemolyzed using an automated analyzer. The samples used in these experiments had GHb concentrations of 4.9% and 8.8%. The differences in measured values were within 0.1% GHb. The time variation between hemolysis and the beginning of analysis did not affect the measured values.
Discussion
The enzymatic assay for GHb encompasses three new technologies, which are integrated into its three reagents.
The first new technology involves the development of the specific protease, which generates fructosyl amino acid only from Hb in blood. Even when plasma is added, no error occurs when this method is used. This means that other proteins in plasma, such as albumin and globulin, do not generate fructosyl amino acid. This new technology makes it possible to use both blood cells and whole blood as samples for the measurement. The specific protease resolves Hb in ϳ5 min and generates fructosyl amino acid.
The second technical advance is the development of FAOD, which reacts only with the fructosyl amino acid generated by the specific protease.
The third new technology involves the development of a method to detect H 2 O 2 in the hemolysate with high sensitivity. When blood cells are hemolyzed, they release catalase and Hb. Catalase removes the H 2 O 2 , and Hb removes the color by decomposing the pigment. These factors cause a large negative error in the measured values. Interference from catalase was eliminated by the activation of POD instead of catalase. Hb is an undesirable interfering substance in serum analysis. With conventional measurement technologies, it was impossible to measure H 2 O 2 in the hemolysate, so that GHb previously could not be measured by enzymatic methods. Interference from Hb was eliminated by combining WST-3, an original interference-removing agent, with Hb. The new technology makes it possible to detect even small amounts of H 2 O 2 in the hemolysate. GHb can now be measured in the hemolysate without the need for separation and purification of the GHb.
The detection principle of the enzymatic assay is the detection of color produced by POD and H 2 O 2 . Because this method provides a rapid and uniform reaction in the same way as clinical biochemistry reagents (e.g., glucose or glutamic oxaloacetic transaminase), excellent precision was obtained with Ͻ1% error. In addition, with this method, GHb and Hb can be measured in the same cell; thus, the error that occurs with the use of an automated analyzer is reduced.
When a sample containing 7% GHb was measured by the conventional immunoassay method, the CV was 3.0%, so that Ϯ 2 SD will be 0.84. This value of Ϯ 2 SD (0.84) is greater than one-half of the reference interval. By contrast, the within-run CV of the new enzymatic assay is Ͻ0.5%, and the total CV is Ͻ1.5%. When a sample containing 7% GHb is measured, Ϯ 2 SD will be 0.14 for within-run imprecision and 0.42 for total imprecision. This value is less than the medically allowable error [e.g., 1% GHb (17 ) and a CV of 3%, which is recommended by the National Glycohemoglobin Standardization Program (18 ) ].
The conventional immunoassay with latex allows cells to deteriorate, and other measurements cannot be conducted on the same material. In contrast, the enzymatic assay does not influence other measurements, so that it can be used with other assays simultaneously on an automated analyzer, thus saving on both the labor and time required for the measurement.
In conclusion, the results produced by the enzymatic assay correlate favorably with those obtained with the conventional methods specific for HbA 1c , such as the HPLC method and immunoassay, but the enzymatic assay provides a comparable or more precise result with a simple and rapid procedure that does not require expensive, dedicated instrumentation.
